Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Overview of attention for article published in New England Journal of Medicine, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 59 news outlets
blogs: 2 blogs
policy: 8 policy sources
twitter: 155 X users
patent: 38 patents
facebook: 15 Facebook pages

wikipedia: 7 Wikipedia pages
f1000: 1 research highlight platform
video: 1 YouTube creator
guideline: 11 clinical guideline sources
podcasts: 6 podcasts

Readers on

mendeley: 1611 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 episodes from 6 podcasts.

Ep. 602 Managing Neuroendocrine Tumors in Interventional Radiology with Dr. Daniel DePietro

BackTable Vascular & Interventional, 30 Dec 2025

What considerations drive your decision between bland embolization, TACE, and radioembolization in managing neuroendocrine…

05_02 Neuroendocrine Tumors

Talking About Tumors with Ryann and Ryan - A medical oncology podcast, 03 May 2025

1. Nomenclature, unique considerations2. Secretory Syndromes3. Somatostatin directed therapy4. Peptide Receptor Radionucleotide…

Clinical Challenges in Surgical Oncology: Neuroendocrine Tumors of the Small Bowel

Behind The Knife: The Surgery Podcast, 17 Feb 2025

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of neuroendocrine…

Episodio 10 - Radionúclidos (estudios NETTER-1 y NETTER-2)

Transworld Health, 19 Nov 2024

Invitados: Dr. Jaume…

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 4 additional posts.